glp 1 nutritional deficiency The GLP-1 Diet: What to Eat (and What to Avoid) for Sustainable Results GLP-1 RA & Nutritional Deficiencies

Glucagon-like peptide-1 (GLP-1) receptor agonists, FDA-approved medications for type 2 diabetes and obesity, are increasingly recognized for potential anti-inflammatory properties beyond their metabolic effects

While this emerging opportunity offers promise, it is currently unresearched

By binding to GLP-1 receptors in the hypothalamus, they reduce appetite and promote satiety, leading to significant weight reduction in clinical trialswith newer agents achieving approximately 15% weight loss in obesity without diabetes (semaglutide) and up to 21% (tirzepatide), with somewhat lower reductions typically seen in patients with type 2 diabetes

Semaglutid (Ozempic, Wegovy): Haftalk enjeksiyon olarak verilen bu ila, hem diyabet hem de obezite tedavisinde etkilidir